NO309125B1 - Anvendelse av 1-alkyl-5-acyl-1,4-dihydropyridiner for fremstilling av legemidler som har en selektiv modulerende virkning på kaliumkanaler, samt utvalgte nye dihydropyridiner - Google Patents

Anvendelse av 1-alkyl-5-acyl-1,4-dihydropyridiner for fremstilling av legemidler som har en selektiv modulerende virkning på kaliumkanaler, samt utvalgte nye dihydropyridiner Download PDF

Info

Publication number
NO309125B1
NO309125B1 NO955104A NO955104A NO309125B1 NO 309125 B1 NO309125 B1 NO 309125B1 NO 955104 A NO955104 A NO 955104A NO 955104 A NO955104 A NO 955104A NO 309125 B1 NO309125 B1 NO 309125B1
Authority
NO
Norway
Prior art keywords
acetyl
trimethyl
carbon atoms
stands
alkyl
Prior art date
Application number
NO955104A
Other languages
English (en)
Norwegian (no)
Other versions
NO955104D0 (no
NO955104L (no
Inventor
Klaus Urbahns
Hans-Georg Heine
Thomas Glaser
Reilinde Wittka
Jean-Marie-Viktor De Vry
Henning Sommermeyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO955104D0 publication Critical patent/NO955104D0/no
Publication of NO955104L publication Critical patent/NO955104L/no
Publication of NO309125B1 publication Critical patent/NO309125B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO955104A 1994-12-16 1995-12-15 Anvendelse av 1-alkyl-5-acyl-1,4-dihydropyridiner for fremstilling av legemidler som har en selektiv modulerende virkning på kaliumkanaler, samt utvalgte nye dihydropyridiner NO309125B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4444864A DE4444864A1 (de) 1994-12-16 1994-12-16 Verwendung von 5-Acyl-1,4-dihydropyridinen

Publications (3)

Publication Number Publication Date
NO955104D0 NO955104D0 (no) 1995-12-15
NO955104L NO955104L (no) 1996-06-17
NO309125B1 true NO309125B1 (no) 2000-12-18

Family

ID=6535989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955104A NO309125B1 (no) 1994-12-16 1995-12-15 Anvendelse av 1-alkyl-5-acyl-1,4-dihydropyridiner for fremstilling av legemidler som har en selektiv modulerende virkning på kaliumkanaler, samt utvalgte nye dihydropyridiner

Country Status (25)

Country Link
US (2) US5646166A (cs)
EP (1) EP0717036B1 (cs)
JP (1) JPH08239364A (cs)
KR (1) KR960022464A (cs)
CN (1) CN1130505A (cs)
AT (1) ATE177735T1 (cs)
AU (1) AU704466B2 (cs)
CA (1) CA2165130A1 (cs)
CZ (1) CZ332995A3 (cs)
DE (2) DE4444864A1 (cs)
DK (1) DK0717036T3 (cs)
EE (1) EE9500075A (cs)
ES (1) ES2130506T3 (cs)
FI (1) FI956015A7 (cs)
GR (1) GR3030319T3 (cs)
HU (1) HUT74185A (cs)
IL (1) IL116387A (cs)
NO (1) NO309125B1 (cs)
NZ (1) NZ280662A (cs)
PL (1) PL311845A1 (cs)
RU (1) RU2158259C2 (cs)
SI (1) SI0717036T1 (cs)
SK (1) SK158195A3 (cs)
TW (1) TW381023B (cs)
ZA (1) ZA9510693B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1459500A (en) * 1998-10-28 2000-05-15 Abbott Laboratories Dihydropyridine compounds and methods of use
MXPA03006605A (es) * 2001-01-30 2003-09-22 Lilly Co Eli Esteres de indol-5-ilo del acido bencensulfonico como antagonistas del receptor 5-ht6.
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
US20050075359A1 (en) * 2003-03-14 2005-04-07 Rikako Kono Large conductance calcium-activated K channel opener
US20060188938A1 (en) * 2005-01-07 2006-08-24 Mullan Michael J Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
EP2782573B1 (en) 2011-11-24 2019-10-09 Richter Gedeon Nyrt. 1,4-dihydropyridine derivatives with hsp modulating activity
CN103420901B (zh) * 2012-05-22 2015-06-17 中国科学院大连化学物理研究所 一种制备1,2-二氢吡啶衍生物的方法
CN103420900B (zh) * 2012-05-22 2015-06-03 中国科学院大连化学物理研究所 一种制备卤代-1,2-二氢吡啶的方法
CN103804286B (zh) * 2012-11-06 2016-07-06 中国科学院大连化学物理研究所 一种由3-氮杂-1,5-烯炔制备吡啶衍生物的方法
CN103804283B (zh) * 2012-11-06 2016-04-20 中国科学院大连化学物理研究所 一种制备1,2-二氢吡啶衍生物的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966948A (en) 1970-01-24 1976-06-29 Bayer Aktiengesellschaft Spasmolytic, vaso-dilating and anti-hypertensive compositions and methods
DE2018739A1 (en) 1970-04-18 1971-10-28 Farbenfabriken Bayer Ag, 5090 Leverkusen 1,4-dihydro-3,5-diacyl-4-arylpyridines,coronary active
DE2018738A1 (en) 1970-04-18 1971-10-28 Farbenfabriken Bayer Ag, 5090 Leverkusen Hydrogenated pyridines, quinolines andacridi
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
FR2649395B1 (fr) * 1989-07-04 1992-11-06 Adir Nouveau derive de la dihydro-1,4 pyridine denomme (-) Ÿi1Ÿ(((amino-2 ethoxy)-2 ethoxy) methylŸi1Ÿ) -2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions qui le contiennent
US5446057A (en) * 1993-09-24 1995-08-29 Warner-Lambert Company Substituted tetrahydropyridine and piperidine carboxylic acids as muscarinic antagonists
JP3709997B2 (ja) * 1994-03-29 2005-10-26 日東電工株式会社 耐熱性ネガ型フォトレジスト組成物および感光性基材、ならびにネガ型パターン形成方法

Also Published As

Publication number Publication date
FI956015L (fi) 1996-06-17
FI956015A0 (fi) 1995-12-14
RU2158259C2 (ru) 2000-10-27
DE59505373D1 (de) 1999-04-22
IL116387A (en) 2000-11-21
SK158195A3 (en) 1996-09-04
US5942526A (en) 1999-08-24
AU4029395A (en) 1996-06-27
US5646166A (en) 1997-07-08
CA2165130A1 (en) 1996-06-17
EE9500075A (et) 1996-06-17
GR3030319T3 (en) 1999-09-30
NZ280662A (en) 1997-02-24
HUT74185A (en) 1996-11-28
TW381023B (en) 2000-02-01
KR960022464A (ko) 1996-07-18
NO955104D0 (no) 1995-12-15
EP0717036A1 (de) 1996-06-19
ATE177735T1 (de) 1999-04-15
IL116387A0 (en) 1996-03-31
FI956015A7 (fi) 1996-06-17
NO955104L (no) 1996-06-17
ES2130506T3 (es) 1999-07-01
ZA9510693B (en) 1996-07-03
CZ332995A3 (en) 1996-07-17
DE4444864A1 (de) 1996-06-20
PL311845A1 (en) 1996-06-24
CN1130505A (zh) 1996-09-11
AU704466B2 (en) 1999-04-22
SI0717036T1 (en) 1999-06-30
JPH08239364A (ja) 1996-09-17
HU9503592D0 (en) 1996-02-28
EP0717036B1 (de) 1999-03-17
DK0717036T3 (da) 1999-10-11

Similar Documents

Publication Publication Date Title
DE69110254T2 (de) Hydroxychinolonderivate.
US6194428B1 (en) Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system
NO326648B1 (no) Polymorf form av rimonabant, fremgangsmate for fremstilling derav og farmasoytisk preparat inneholdende det samme.
JPH09505829A (ja) 炎症および炎症関連障害を処置するための１，４，５−トリフェニルピラゾリル化合物
KR20180132661A (ko) 뎅기 바이러스 복제 억제제로서의 치환 인돌린 유도체
US5670525A (en) Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders
US5426106A (en) Pyrrolo-pyridazinone derivatives
US5861394A (en) Use of N-substituted phenothiazines
JPH09512542A (ja) Ｄ▲下４▼リセプタ拮抗剤としてのベンゾフラン誘導体
US5942526A (en) 5-acyl-1,4-dihydropyridines
US6121284A (en) 2,3-bridged 1,4-dihydropyridines, and their use as medicaments
US5756515A (en) Dioxo-thiopyrano-pyridine-carboxylic acid derivatives and their use as medicaments
US5874462A (en) Use of substituted 6-amino-4H-pyrans
US5665741A (en) 1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of neuronal diseases
US6147087A (en) Use of 1,2-Bridged 1,4-dihydropyridines as medicaments
WO2008069469A1 (en) Crystalline s-(-)-amlodipine camsylate anhydride and preparation method thereof
US5652264A (en) Cyclohexadiene derivatives useful in the treatment of depression
US5719181A (en) Use of acyl-substituted aminopyrans
JPH0352888A (ja) 新規化合物、その製法及びそれを含む医薬組成物
KR20170029513A (ko) 후안부 질환의 예방 또는 치료제

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2002